Evaluating the impact of treating the optimal subgroup

被引:22
作者
Luedtke, Alexander R. [1 ]
van der Laan, Mark J. [2 ]
机构
[1] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA
[2] Univ Calif Berkeley, Div Biostat, Berkeley, CA 94720 USA
关键词
Individualized treatment; non-regular inference; stabilized one-step estimator; subgroup analyses; INFERENCE; TRIALS;
D O I
10.1177/0962280217708664
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Suppose we have a binary treatment used to influence an outcome. Given data from an observational or controlled study, we wish to determine whether or not there exists some subset of observed covariates in which the treatment is more effective than the standard practice of no treatment. Furthermore, we wish to quantify the improvement in population mean outcome that will be seen if this subgroup receives treatment and the rest of the population remains untreated. We show that this problem is surprisingly challenging given how often it is an (at least implicit) study objective. Blindly applying standard techniques fails to yield any apparent asymptotic results, while using existing techniques to confront the non-regularity does not necessarily help at distributions where there is no treatment effect. Here, we describe an approach to estimate the impact of treating the subgroup which benefits from treatment that is valid in a nonparametric model and is able to deal with the case where there is no treatment effect. The approach is a slight modification of an approach that recently appeared in the individualized medicine literature.
引用
收藏
页码:1630 / 1640
页数:11
相关论文
共 31 条
[1]  
Abadie A., 2013, 19742 NBER
[2]   Subgroup analysis and other (mis)uses of baseline data in clinical trials [J].
Assmann, SF ;
Pocock, SJ ;
Enos, LE ;
Kasten, LE .
LANCET, 2000, 355 (9209) :1064-1069
[3]  
Bickel P. J., 1993, Efficient and Adaptive Estimation for Semiparametric Models
[4]   MARTINGALE CENTRAL LIMIT THEOREMS [J].
BROWN, BM .
ANNALS OF MATHEMATICAL STATISTICS, 1971, 42 (01) :59-&
[5]  
Chakraborty B., 2013, Statistical methods for dynamic treatment regimes
[6]   Inference about the expected performance of a data-driven dynamic treatment regime [J].
Chakraborty, Bibhas ;
Laber, Eric B. ;
Zhao, Ying-Qi .
CLINICAL TRIALS, 2014, 11 (04) :408-417
[7]   General guidance on exploratory and confirmatory subgroup analysis in late-stage clinical trials [J].
Dmitrienko, Alex ;
Muysers, Christoph ;
Fritsch, Arno ;
Lipkovich, Ilya .
JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2016, 26 (01) :71-98
[8]   Commentary: The problem of cogent subgroups: A clinicostatistical tragedy [J].
Feinstein, AR .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1998, 51 (04) :297-299
[9]   Limitations of applying summary results of clinical trials to individual patients - The need for risk stratification [J].
Kent, David M. ;
Hayward, Rodney A. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (10) :1209-1212
[10]   The challenge of subgroup analyses - Reporting without distorting [J].
Lagakos, SW .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (16) :1667-1669